Treatment of Dysfunctional Uterine Bleeding with Danazol
article
OA: closed
CC0
⤵ 10 in-corpus citations
AI-generated summary
Danazol treatment significantly reduced menstrual blood loss in women with dysfunctional uterine bleeding, with higher doses leading to amenorrhea in most patients.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Twenty-six women completed a 6-month course of treatment with danazol (at various dosages between 200 and 800 mg daily) for menorrhagia due to dysfunctional uterine bleeding. Objective measurements of menstrual blood loss (MBL) were undertaken in 9 women, while the remainder merely recorded a detailed prospective but subjective menstrual calendar. A very substantial decrease in blood loss was recorded by all women, and the majority of women on 400-800 mg daily developed amenorrhoea by 3 months. Six women experienced episodes of prolonged or frequent bleeding or spotting throughout the 6 months. Three women used 200 mg daily throughout with a mean measured MBL falling from 95.3 ml to less than 14 ml per month after 2 months therapy. This may become a valuable therapy for menorrhagia for women requiring temporary medical management. However, possibilities for long-term therapy may be limited in some women by side-effects and metabolic effects.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (14)
- Cholesterol, High Density Lipoprotein and Danazol via openalex
- Classification of side-effects to danazol therapy. via openalex
- Danazol—A Steroid with a Unique Combination of Actions via openalex
- Efficacy of mefenamic acid in patients with a complaint of menorrhagia. via openalex
- Preliminary results on clinical and endocrine studies in the treatment of menorrhagia with danazol. via openalex
- Review: The Mechanism of Action of Danazol, a Novel Steroid Derivative via openalex
- THE EFFECT OF DANAZOL ON MENORRHAGIA, COAGULATION MECHANISMS, HAEMATOLOGICAL INDICES AND BODY WEIGHT via openalex
- doi:10.1016/0002-9378(81)90611-6 via openalex
- doi:10.1016/0002-9378(84)90123-6 via openalex
- doi:10.3109/00365516409060511 via openalex
- doi:10.1080/00365516409060511 via openalex
- doi:10.1016/0002-9378(84)90308-9 via openalex
- doi:10.1016/0010-7824(77)90026-9 via openalex
- doi:10.1097/00006254-198205000-00015 via openalex
Cited by (10)
- Effect of dienogest on bleeding time, coagulation, fibrinolysis, and platelet aggregation in female rats 1999
- Uterus and endometrium: Microvascular density in conditions of endometrial atrophy 1996
- HYSTEROSCOPIC ENDOMETRIAL ABLATION 1995
- Assessment of medical treatments for menorrhagia 1994
- Management of Dysfunctional Uterine Bleeding 1992
- Danazol in the Treatment of Menorrhagia: The Effect of a 1 Month Induction Dose (200 mg) and 2 Month's Maintenance Therapy (200 mg, 100 mg, 50 mg or placebo) 1992
- Risk-Benefit Assessment of Drugs Used for the Treatment of Menstrual Disorders 1991
- Dysfunctional uterine bleeding in adolescent and teenage girls 1990
- 11 Treatment of menorrhagia 1989
- Treatment of laparoscopically confirmed endometriosis with danazol 1989
Source provenance
- openalex
- last seen: 2026-05-11T04:37:08.017751+00:00
License: CC0
· commercial use OK